Biohaven (BHVN) Change in Account Payables (2021 - 2026)

Biohaven (BHVN) reported Change in Account Payables of -$1.2 million for Q1 2026, down 1441.76% on a YoY basis from $91000.0 in Q1 2025, and up 79.12% sequentially from -$5.8 million in Q4 2025.

Biohaven (BHVN) Change in Account Payables (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 1441.76% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$7.7 million (up 57.85% YoY), and the FY2025 full-year result was -$6.4 million, down 999.44% from the prior year.
  • Change in Account Payables climbed to -$1.2 million in Q1 2026, from -$5.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $19.1 million in Q1 2024 to a low of -$19.1 million in Q2 2024.
  • A 5-year average of $229705.9 and a median of -$325000.0 in 2022 frame the typical range for Change in Account Payables.
  • Across the five-year window, Change in Account Payables jumped 408.02% in 2024 and plunged 1441.76% in 2026, its largest moves.
  • Tracing BHVN's Change in Account Payables over 5 years: stood at $6.0 million in 2022, then advanced by 1.51% to $6.1 million in 2023, then slumped by 128.29% to -$1.7 million in 2024, then sank by 240.99% to -$5.8 million in 2025, then soared by 79.12% to -$1.2 million in 2026.
  • Business Quant data shows BHVN's Change in Account Payables at -$1.2 million in Q1 2026, -$5.8 million in Q4 2025, and -$2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn -42.19 Mn
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn -
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn -
10 Biohaven 2.16 Bn 1.81 Bn - -1.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.22 Mn
Mar 31, 2026 -1.22 Mn
Dec 31, 2025 -5.85 Mn
Dec 31, 2025 -5.85 Mn
Sep 30, 2025 -2.14 Mn
Sep 30, 2025 -2.14 Mn
Jun 30, 2025 1.51 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 91,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 -1.72 Mn
Dec 31, 2024 -1.72 Mn
Sep 30, 2024 2.49 Mn
Sep 30, 2024 2.49 Mn
Jun 30, 2024 -19.13 Mn
Jun 30, 2024 -19.13 Mn
Mar 31, 2024 19.07 Mn
Mar 31, 2024 19.07 Mn
Dec 31, 2023 6.06 Mn
Dec 31, 2023 6.06 Mn